Department of Endocrinology, Centre Hospitalier Universitaire de Liège, Liège Université, Domaine Universitaire Sart-Tilman, Liège 4000, Belgium.
Endocrinol Metab Clin North Am. 2020 Sep;49(3):347-355. doi: 10.1016/j.ecl.2020.04.002. Epub 2020 Jun 10.
Pituitary adenomas are usually nonmalignant, but have a heavy burden on patients and health care systems. Increased availability of MRI has led to an increase in incidentally found pituitary lesions and clinically relevant pituitary adenomas. Epidemiologic studies show that pituitary adenomas are increasing in incidence (between 3.9 and 7.4 cases per 100,000 per year) and prevalence (76 to 116 cases per 100,000 population) in the general population (approximately 1 case per 1000 of the general population). Most new cases diagnosed are prolactinomas and nonsecreting pituitary adenomas. Most clinically relevant pituitary adenomas occur in females, but pituitary adenomas are clinically heterogeneous.
垂体腺瘤通常为良性,但会给患者和医疗保健系统带来沉重负担。磁共振成像(MRI)的应用日益普及,导致偶然发现的垂体病变和有临床意义的垂体腺瘤数量增加。流行病学研究表明,垂体腺瘤的发病率(每年每 10 万人中有 3.9 至 7.4 例)和患病率(每 10 万人中有 76 至 116 例)在普通人群中均有所增加(约占普通人群的 1/1000)。新诊断出的大多数病例为催乳素瘤和无分泌功能的垂体腺瘤。大多数有临床意义的垂体腺瘤发生在女性中,但垂体腺瘤在临床上存在异质性。